Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

Cited by (1,001)

Items 501–600 of 1,001

1. Kidney Parameters with Tirzepatide in Obesity with or without Type 2 Diabetes
   Heerspink, Hiddo J.L., Friedman, Allon N., Bjornstad, Petter, van Raalte, Daniel H., Cherney, David, Cao, Dachuang, Garcia-Pérez, Luis-Emilio, Stefanski, Adam, Turfanda, Ibrahim, Bunck, Mathijs C. et al. · 2025 · Journal of the American Society of Nephrology
2. Competing Risk of Death With End-Stage Renal Disease in Diabetic Kidney Disease
   Yue Jiang, Jason P. Fine, Amy K. Mottl · 2018 · Advances in Chronic Kidney Disease
3. Short chain fatty acids for the risk of diabetic nephropathy in type 2 diabetes patients
   Yang Li, Guo-Qiang Qin, Wanying Wang, Xu Liu, Xiaoqian Gao, Junhui Liu, Tao Zheng, Wei Zhang, Lan Cheng, Kun Yang et al. · 2022 · Acta Diabetologica
4. Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence
   Meir Schechter, Cheli Melzer Cohen, Alisa Fishkin, Aliza Rozenberg, Ilan Yanuv, Dvora Rywka Sehtman-Shachar, Gabriel Chodick, Alice Clark, Trine Julie Abrahamsen, Jack Lawson et al. · 2023 · Cardiovascular Diabetology
5. Chronic kidney disease in primary care: risk of cardiovascular events, end stage kidney disease and death
   Rikke Borg, Margit Kriegbaum, Mia Klinten Grand, Bent Lind, Christen Lykkegaard Andersen, Frederik Persson · 2023 · BMC Family Practice
6. Efficacy and Safety of the Use of SGLT2 Inhibitors in Patients on Incremental Hemodialysis: Maximizing Residual Renal Function, Is There a Role for SGLT2 Inhibitors?
   Jose Carlos de la Flor, Daniel E. Villa, Leónidas Luis Cruzado Vega, Jacqueline Apaza, Francisco Valga, Rocío Zamora, Alexander Marschall, Michael Cieza Terrones, Javier Deira, Miguel Rodeles · 2023 · Biomedicines
7. Associations Between Albuminuria and Mortality Among US Adults by Demographic and Comorbidity Factors
   Yelena R. Drexler, Julien O. Tremblay, Robert A. Mesa, Bailey Parsons, Efren Chavez, Gabriel N. Contreras, Alessia Fornoni, Leopoldo R. Raij, Samuel L. Swift, Tali Elfassy · 2023 · Journal of the American Heart Association
8. Impact of mild to moderate reductions of glomerular filtration rate on coronary artery disease severity
   Andrea Natali, Beatrice Boldrini, Simona Baldi, M. Rossi, Patrizia Landi, Silva Severi, Anna Solini, Ele Ferrannini · 2013 · Nutrition Metabolism and Cardiovascular Diseases
9. Hereditary amyloidosis caused by R554L fibrinogen Aα-chain mutation in a Spanish family and review of the literature
   Michael Haidinger, Johannes M. Werzowa, Renate Kain, Marlies Antlanger, Manfred Hecking, Stefan Pfaffenberger, Julia Mascherbauer, Thomas Gremmel, Janet A. Gilbertson, Dorota M. Rowczenio et al. · 2013 · Amyloid
10. Associations of estimated glomerular filtration rate and blood urea nitrogen with incident coronary heart disease: the Dongfeng-Tongji Cohort Study
    Haijing Jiang, Jun Li, Kuai Yu, Handong Yang, Xinwen Min, Huanqian Chen, Tangchun Wu · 2017 · Scientific Reports
11. Normoalbuminuric kidney impairment in patients with T1DM: insights from annals initiative
    Olga Lamacchia, Francesca Chiara Viazzi, Paola Fioretto, Antonio Mirijello, Carlo Bruno Giorda, Antonio Ceriello, Giuseppina Tiziana Russo, Pietro Guida, Roberto Pontremoli, Salvatore De Cosmo · 2018 · Diabetology & Metabolic Syndrome
12. Systematic DOACs oral anticoagulation in patients with atrial fibrillation and chronic kidney disease: the nephrologist’s perspective
    Maura Ravera, Elisabetta Bussalino, Maria Fusaro, Luca Di Lullo, Filippo Aucella, Ernesto Paoletti · 2020 · Journal of Nephrology
13. Addition of Metabolic Syndrome to Albuminuria Provides a New Risk Stratification Model for Diabetic Kidney Disease Progression in Elderly Patients
    Hong‐Mou Shih, Shih‐Ming Chuang, Chun‐Chuan Lee, Sung-Chen Liu, Ming-Chieh Tsai · 2020 · Scientific Reports
14. Impact of extracellular‐to‐intracellular fluid volume ratio on albuminuria in patients with type 2 diabetes: A cross‐sectional and longitudinal cohort study
    Hanako Nakajima, Yoshitaka Hashimoto, Ayumi Kaji, Ryosuke Sakai, Fuyuko Takahashi, Yuta Yoshimura, Ryo Bamba, Takuro Okamura, Noriyuki Kitagawa, Saori Majima et al. · 2020 · Journal of Diabetes Investigation
15. Time-Updated Changes in Estimated GFR and Proteinuria and Major Adverse Cardiac Events: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study
    Jordana B. Cohen, Wei Peter Yang, Liang Li, Xiaoming Zhang, Zihe Zheng, Paula Orlandi, Nisha Bansal, Rajat Deo, James Phillip Lash, Mahboob Rahman et al. · 2021 · American Journal of Kidney Diseases
16. Relationship between hypertension, diabetes and proteinuria in rural and urban households in Yemen
    Pietro Amedeo Modesti, Mohamed Bamoshmoosh, Stefano Rapi, Luciano Massetti, Stefano Bianchi, Dawood Abdul Malek Yahya Al-Hidabi, Husni Al Goshae · 2013 · Journal of Human Hypertension
17. The protective effects of ischemic preconditioning on rats with renal ischemia-reperfusion injury and the effects on the expression of Bcl-2 and Bax
    Sheng Shen, Jiexue Zhou, Shandong Meng, Jiaqing Wu, Juan Ma, Chunli Zhu, Gengguo Deng, Dong Liu · 2017 · Experimental and Therapeutic Medicine
18. Vascular Dysfunction: A Key Player in Chronic Cardio-renal Syndrome
    Hirofumi Tomiyama, Akira Yamashina · 2015 · Internal Medicine
19. Diabetes mellitus type 1 in adults
    Ivan Ivanovich Dedov, Marina Vladimirovna Shestakova, Alexander Y. Mayorov, Минара Шамхаловна Шамхалова, Tatiana Vasil'evna Nikonova, Olga Yu. Sukhareva, Елена Владимировна Пекарева, Liudmila I. Ibragimova, Михина Маргарита Сергеевна, Gagik Radikovich Galstyan et al. · 2020 · Diabetes Mellitus
20. Albuminuria rather than glomerular filtration rate is associated with vascular endothelial function in patients with type 2 diabetes
    Yoshinori Kakutani, Tomoaki Morioka, Katsuhito Mori, Yuko Yamazaki, Akinobu Ochi, Masafumi Kurajoh, Shinya Fukumoto, Atsushi Shioi, Tetsuo Shoji, Masaaki Inaba et al. · 2020 · Journal of Diabetes and its Complications
21. Prediabetes is associated with proteinuria development but not with glomerular filtration rate decline: A longitudinal observational study
    Mariko Furukawa, Takeshi Onoue, Kiminori Kato, Takashi Wada, Yukito Shinohara, Fumie Kinoshita, Motomitsu Goto, Hiroshi Arima, Kazuyo Tsushita · 2021 · Diabetic Medicine
22. Chronic kidney disease: prevalence and association with handgrip strength in a cross-sectional study
    Cheng Yang, Min Liu, Yu Liu, Haifeng Xu, Xiaotian Chen, Hui Wen Zheng, Xiaojun Wu, Zhixiang Shen, Chong Shen · 2021 · BMC Nephrology
23. Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes
    Emanuela Orsi, Anna Solini, Enzo Bonora, Martina Vitale, Monia Garofolo, Cecilia Fondelli, Roberto Trevisan, Monica Vedovato, Franco Luigi Cavalot, Gianpaolo Zerbini et al. · 2022 · Diabetes & Metabolism
24. Association of sarcopenia with rapid kidney function decline and chronic kidney disease in adults with normal kidney function
    Xiaowei Zheng, Xiao Ren, Minglan Jiang, Longyang Han, Chongke Zhong · 2023 · British Journal Of Nutrition
25. Inter‐relationships between cardiovascular, renal and metabolic diseases: Underlying evidence and implications for integrated interdisciplinary care and management
    Jiten P Vora, David Z.I. Cherney, Mikhail Kosiborod, Jonas Spaak, Naresh Kanumilli, Kamlesh K. Khunti, Carolyn S.P. Lam, Michael Bachmann, Peter Fenici, the CaReMe Global Alliance · 2024 · Diabetes Obesity and Metabolism
26. Association between systemic immune-inflammation index and chronic kidney disease: A population-based study
    Lin Li, Kunfei Chen, Chengping Wen, Xiaoqin Ma, Lin Huang · 2024 · PLoS ONE
27. Population-based dose-response curve of glomerular filtration rate to dietary protein intake.
    M. Cirillo, F. Zingone, C. Lombardi, P. Cavallo, A. Zanchetti, G. Bilancio · 2015 · Nephrology, Dialysis and Transplantation
28. Should an Elderly Patient with Stage V CKD and Dementia Be Started on Dialysis?
    Irene Ying, Zoe Levitt, Sarbjit Vanita Jassal · 2013 · Clinical Journal of the American Society of Nephrology
29. Cardiac and vascular changes with kidney transplantation
    A Ali, Iain A. M. MacPhee, J C Kaski, Debasish Banerjee · 2015 · Indian Journal of Nephrology
30. Comparison of cystatin C- and creatinine-based estimated glomerular filtration rates for predicting all-cause mortality in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry
    Hitoshi Ide, Masanori Iwase, Hiroki Fujii, Toshiaki Ohkuma, Shinako Kaizu, Tamaki Jodai, Yohei Kikuchi, Yasuhiro Idewaki, Akiko Sumi, Udai Nakamura et al. · 2016 · Clinical and Experimental Nephrology
31. Kidney Function Estimated From Cystatin C, But Not Creatinine, Is Related to Objective Tests of Physical Performance in Community-Dwelling Older Adults
    Mark Canney, Donal J. Sexton, Matthew D. L. O’Connell, Rose Anne Kenny, Mark Alan Little, Conall M. O’Seaghdha · 2017 · The Journals of Gerontology Series A
32. The Role of Vildagliptin in the Therapy of Type 2 Diabetic Patients with Renal Dysfunction
    Roberto Trevisan · 2017 · Diabetes Therapy
33. Proteomic analysis of heart failure hospitalization among patients with chronic kidney disease: The Heart and Soul Study
    Ruth F. Dubin, Mary A. Whooley, Alexander R. Pico, Peter Ganz, Nelson B. Schiller, Craig S. Meyer · 2018 · PLoS ONE
34. Lipid-modifying therapy in chronic kidney disease: Pathophysiological and clinical considerations
    Gunnar Henrik Heine, Kathrin Eller, Julia T. Stadler, Kyrill Sebastian Rogacev, Gunther Marsche · 2019 · Pharmacology & Therapeutics
35. Could antioxidant supplementation delay progression of cardiovascular disease in end-stage renal disease patients?
    S. Roumeliotis, A. Roumeliotis, Xenia Gorny, P. Mertens · 2020 · Current Vascular Pharmacology
36. Sarcopenic obesity is associated with macroalbuminuria in patients with type 2 diabetes: a cross-sectional study
    Fuyuko Takahashi, Yoshitaka Hashimoto, Ayumi Kaji, Ryosuke Sakai, Takuro Okamura, Masahide Hamaguchi, Michiaki Fukui · 2021 · Endocrine Journal
37. Apolipoprotein B Attenuates Albuminuria-Associated Cardiovascular Disease in Prevention of Renal and Vascular Endstage Disease (PREVEND) Participants
    James P. Corsetti, Ron T. Gansevoort, Stephan J. L. Bakker, Charles E. Sparks, Priya Vart, Robin P. F. Dullaart · 2014 · Journal of the American Society of Nephrology
38. What drives quality improvement in chronic kidney disease (CKD) in primary care: process evaluation of the Quality Improvement in Chronic Kidney Disease (QICKD) trial
    Akın Nihat, Simon de Lusignan, Nicola Thomas, Mohammad Aumran Tahir, Hugh Gallagher · 2016 · BMJ Open
39. Specific Blood Pressure Targets for Patients With Diabetic Nephropathy?
    Guido M. Grassi, Giuseppe Mancia, Peter M. Nilsson · 2016 · Diabetes Care
40. Dapagliflozin, advanced chronic kidney disease, and mortality: new insights from the DAPA-CKD trial
    Nikolaus Marx, Jürgen Floege · 2021 · European Heart Journal
41. Knockdown of lncRNA NORAD inhibits the proliferation, inflammation and fibrosis of human mesangial cells under high‑glucose conditions by regulating the miR‑485/NRF1 axis
    Linna Wang, Xiao‐Ying Yuan, Lifeng Lian, Huali Guo, Hongxia Zhang, Minghui Zhang · 2021 · Experimental and Therapeutic Medicine
42. SGLT2 Inhibitors: The Next Blockbuster Multifaceted Drug?
    Jonathan C.H. Chan, Michael C. Y. Chan · 2023 · Medicina
43. Kidney and Heart Failure Events are Bidirectionally Associated in Patients with Type 2 Diabetes and Cardiovascular Disease
    Abhinav Sharma, Silvio E. Inzucchi, Jeffrey Moore Testani, Anne Pernille Ofstad, David Fitchett, Michaela Mattheus, Subodh Verma, Faiez M. Zannad, Christoph Wanner, Bettina Johanna Kraus · 2023 · ESC Heart Failure
44. Thonningianin A ameliorated renal interstitial fibrosis in diabetic nephropathy mice by modulating gut microbiota dysbiosis and repressing inflammation
    Shujiao Zhang, Shuaixing Zhang, Xuehui Bai, Yaoxian Wang, Yuning Liu, Weijing Liu · 2024 · Frontiers in Pharmacology
45. Impact of DPP-4 Inhibitors in Patients with Diabetes Mellitus and Heart Failure: An In-Depth Review
    Francisco Epelde · 2024 · Medicina
46. Renal protection with calcium antagonists: the role of lercanidipine
    Michel Burnier · 2013 · Current Medical Research and Opinion
47. Management of lipids in adults with diabetes mellitus and nephropathy and/or chronic kidney disease: summary of joint guidance from the Association of British Clinical Diabetologists (ABCD) and the Renal Association (RA)
    Patrick Barry Mark, Peter H. Winocour, Caroline Day · 2017 · British Journal of Diabetes
48. Albuminuric and non-albuminuric chronic kidney disease in type 1 diabetes: Association with major vascular outcomes risk and all-cause mortality
    Monia Garofolo, Eleonora Russo, Roberto Miccoli, Daniela Lucchesi, Laura Giusti, Veronica Sancho‐Bornez, Giuseppe Daniele, Stefano Del Prato, Giuseppe Penno · 2018 · Journal of Diabetes and its Complications
49. Healthcare resource utilisation for chronic kidney disease and other major non-communicable chronic diseases in China: a cross-sectional study
    Chao Yang, Jianyan Long, Ying Shi, Zhiye Zhou, Jinwei Wang, Ming‐Hui Zhao, Haibo Wang, Luxia Zhang, Josef Coresh · 2022 · BMJ Open
50. Diabetes mellitus, hypertension and albuminuria in rural Z ambia: a hospital‐based survey
    Jon Rasmussen, Jakúp A. Thomsen, Peter R Rossing, Shelagh Parkinson, Dirk L. Christensen, Ib Christian Bygbjerg · 2013 · Tropical Medicine & International Health
51. Renal denervation using carbon dioxide renal angiography in patients with uncontrolled hypertension and moderate to severe chronic kidney disease
    Mohammed Awais Hameed, Jonathan Freedman, Richard W. Watkin, Arul Ganeshan, Indranil Dasgupta · 2017 · Clinical Kidney Journal
52. Prevalence of microalbuminuria in hypertensive patients with or without type 2 diabetes in a Portuguese primary care setting: The RACE (micRoAlbumin sCreening survEy) study
    Pedro Marques da Silva, Davide Maurício Carvalho, José Nazaré, Luís Martins, Carlos Aguíar, Maria Conceição Manso, Teresa Carqueja, Jorge Junqueira Polónia · 2015 · Revista Portuguesa de Cardiologia (English Edition)
53. Effectiveness of adherence to a renal health program in a health network in Peru
    Jessica Bravo-Zúñiga, Enrique M. Saldarriaga, Ricardo Chávez-Gómez, Jungmei Gálvez-Inga, Renzo P. Valdivia-Vega, Mirko Villavicencio-Carranza, José Espejo-Sotelo, C. Medina, Víctor Suárez, Yamilee Hurtado-Roca · 2020 · Revista de Saúde Pública
54. Cyclooxygenase-2 contributes to diabetic nephropathy through glomerular EP4 receptor
    Yi Guan, Linda S. Davis, Matthew Douglas Breyer, Chuan‐Ming Hao · 2022 · Prostaglandins & Other Lipid Mediators
55. The impact of gender on the risk of cardiovascular events in older adults with advanced chronic kidney disease
    Megan E Astley, Fergus John Caskey, Marie Evans, Claudia Torino, Maciej Szymczak, Christiane Drechsler, Maria Pippias, Esther N. M. de Rooij, Gaetana Porto, Vianda S Stel et al. · 2023 · Clinical Kidney Journal
56. From Diabetic Nephropathy to End-Stage Renal Disease: The Effect of Chemokines on the Immune System
    Yuheng Qiu, Jingyi Tang, Qihan Zhao, Yuhua Jiang, Yuning Liu, Wei Jing Liu · 2023 · Journal of Diabetes Research
57. Optimization of guideline-directed medical therapies in patients with diabetes and chronic kidney disease
    Joshua J. Neumiller, Radica Z. Alicic, Katherine R. Tuttle · 2023 · Clinical Kidney Journal
58. Flexible Ureterorenoscopy Is Safe and Efficient for the Treatment of Kidney Stones in Patients With Chronic Kidney Disease
    Emrah Yürük, Murat Binbay, Faruk Özgör, Akif Erbin, Y. Berberoğlu, Ahmet Yaser Müslümanoğlu · 2014 · Urology
59. Impact of chronic kidney disease on the prevalence of cardiovascular disease in patients with type 2 diabetes in Spain: PERCEDIME2 study
    Antonio Rodríguez‐Poncelas, Gabriel Coll de Tuero, Oriol Turró Garriga, Joan Barrot, Josep Franch‐Nadal, Xavier Mundet, on behalf RedGDPS Study Group · 2014 · BMC Nephrology
60. Sex‐Specific Differences in Cardiovascular Risk Factors and Blood Pressure Control in Hypertensive Patients
    Κωνσταντίνος Τζιόμαλος, Vasilios Giampatzis, Maria S. Baltatzi, Elias Efthymiou, Κωνσταντία Ψιάνου, Natalia Papastergiou, Dimitra Magkou, Vagia Bougatsa, Christos G. Savopoulos, Apostolos Ioannis Hatzitolios · 2014 · Journal of Clinical Hypertension
61. Correlation between Carotid Intima–Media Thickness and Early-Stage Chronic Kidney Disease: Results from Asymptomatic Polyvascular Abnormalities in Community Study
    Yu Wu, Jinhong Hou, Junjuan Li, Yang Luo, Shouling Wu · 2015 · Journal of Stroke and Cerebrovascular Diseases
62. Risk Stratification of Coronary Artery Disease in Asymptomatic Diabetic Subjects Using Multidetector Computed Tomography
    Michio Shimabukuro, Taro Saito, Toru Higa, Keita Nakamura, Hiroaki Masuzaki, Masataka Sata, the Fukuoka diabetologists group · 2015 · Circulation Journal
63. Diabetic Kidney Disease: A Determinant of Cardiovascular Risk in Type 1 Diabetes
    Ian H. de Boer, George L. Bakris · 2018 · Diabetes Care
64. Prevalence and risk factors associated with chronic kidney disease in adults living in 3 different altitude regions in the Tibetan Plateau
    Linfeng Zhang, Zengwu Wang, Yundai Chen, Xin Wang, Zuo Chen, Bin Feng, Qinglei Zhu, Jingyu Nie, Ying Dong, Shanshan Zhou et al. · 2018 · Clinica Chimica Acta
65. Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events in patients with diabetes and overt nephropathy: a meta-analysis of randomised controlled trials
    Fan Shunan, Yuan Jiqing, Dong Xue · 2018 · Journal of the Renin-Angiotensin-Aldosterone System
66. Non-Tuberculous Mycobacteria Interference with BCG-Current Controversies and Future Directions
    Deepshikha Verma, Edward D. Chan, Diane J. Ordway · 2020 · Vaccines
67. Diagnosis, prevention, and treatment of cardiovascular diseases in people with type 2 diabetes and prediabetes: a consensus statement jointly from the Japanese Circulation Society and the Japan Diabetes Society
    the directors of the JCS, JDS, Eiichi Araki, Atsushi Tanaka, Nobuya Inagaki, Hiroshi Ito, Kohjiro Ueki, Toyoaki Murohara, Kenjiro Imai, Masataka Sata, Takehiro Sugiyama et al. · 2020 · Diabetology International
68. Endothelial Dysfunction Is Associated with Cerebrovascular Events in Pre-Dialysis CKD Patients: A Prospective Study
    Ana Cerqueira, Janete Quelhas‐Santos, Susana Sampaio, Inês Castro Ferreira, Miguel Relvas, Nídia Marques, Cláudia Camila Dias, Manuel Pestana · 2021 · Life
69. High normal albuminuria is associated with arterial stiffness and carotid atherosclerosis in Korean patients with type 2 diabetes
    Hye Eun Yoon, E.S. Kim, Eun Yeong Mo, Seok Joon Shin, Sung Dae Moon, Je Ho Han · 2015 · Nutrition Metabolism and Cardiovascular Diseases
70. Vascular access placement in patients with chronic kidney disease Stages 4 and 5 attending an inner city nephrology clinic: a cohort study and survey of providers
    Narender Goel, Caroline Kwon, Teena P. Zachariah, Michael Broker, Vaughn W. Folkert, Carolyn A. Bauer, Michal L. Melamed · 2017 · BMC Nephrology
71. Sex-Differences in Renal Expression of Selected Transporters and Transcription Factors in Lean and Obese Zucker Spontaneously Hypertensive Fatty Rats
    Andrea Bábelová, Birgitta Christina Burckhardt, Waja Wegner, Gerhard Burckhardt, Maja Henjakovic · 2015 · Journal of Diabetes Research
72. Association of chronic kidney disease with postoperative outcomes: a national surgical quality improvement program (NSQIP) multi-specialty surgical cohort analysis
    Carlos Andres Riveros, Sanjana Ranganathan, Yash Shah, Emily Huang, Jiaqiong Xu, Enshuo Hsu, Michael Geng, Siqi Hu, Zachary Melchiode, Brian J. Miles et al. · 2024 · BMC Nephrology
73. Prevalence and risk factors for pulmonary arterial hypertension in end-stage renal disease patients undergoing continuous ambulatory peritoneal dialysis
    Lei Zhang, Shiqi Zhao, Jinling Ma, Jian Gong, Gui-Zhen Qiu, Yueqin Ren, Ying Zen, Yongbing Shi · 2016 · Renal Failure
74. Haemorragic and thromboembolic risk in CKD patients with non valvular atrial fibrillation: Do we need a novel risk score calculator?
    Maura Ravera, Elisabetta Bussalino, Ernesto Paoletti, Antonio Bellasi, Luca Di Lullo, Maria Fusaro · 2018 · International Journal of Cardiology
75. Hospitalization Rates in Older Adults With Albuminuria: The Cardiovascular Health Study
    Joshua I. Barzilay, Petra Bůžková, Michael G. Shlipak, Nisha Bansal, Pranav Sandilya Garimella, Kenneth Jay Mukamal · 2020 · The Journals of Gerontology Series A
76. Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort
    Elisa Dal Canto, Petra J. M. Elders, Amber A. W. A. van der Heijden, Adriana Johanne van Ballegooijen, Birgit Ilja Lissenberg-Witte, Femke Rutters, Joline W. J. Beulens · 2022 · Diabetologia
77. Sodium-Glucose Cotransporter 2 Inhibitors and Kidney Outcomes across the Spectrum of Kidney Disease
    Bernardo Frison Spiazzi, Giovana Fagundes Piccoli, Laura Fink Wayerbacher, João Pedro Neves Lubianca, Bruno G. Scalco, Mariana Hollmann Scheffler, Bruna L. Fraga, Verônica Colpani, Fernando Gerchman · 2024 · Clinical Journal of the American Society of Nephrology
78. Clinical and pathological analysis of renal damage in elderly patients with type 2 diabetes mellitus
    Shuangtong Yan, Junyan Liu, Hui Tian, Chunlin Li, Jian Li, Yinghong Shao, Huaiyin Shi, Yu Liu, Yanping Gong, Fusheng Fang et al. · 2015 · Clinical and Experimental Medicine
79. Clustering of chronic kidney disease and cardiovascular risk factors in South-West Nigeria
    R. Oluyombo, M. Olamoyegun, O. Ayodele, P. Akinwusi, A. Akinsola · 2017 · Journal of Nephropathology
80. Do attributes of persons with chronic kidney disease differ in low-income and middle-income countries compared with high-income countries? Evidence from population-based data in six countries
    Shuchi Anand, Yuanchao Zheng, Maria E. Montez‐Rath, Wang Jin Wei, Norberto Perico, Sergio Carminati, K.M. Venkat Narayan, Nikhil Tandon, Viswanathan Mohan, Vivekanand Jha et al. · 2017 · BMJ Global Health
81. Change in Albuminuria and Risk of Renal and Cardiovascular Outcomes: Natural Variation Should Be Taken into Account
    Margaret C Smith, William Guy Herrington, Misghina Weldegiorgis, Richard F. Hobbs, Clare R Bankhead, Mark Woodward · 2018 · Kidney International Reports
82. Downregulation of MiR-218 can alleviate high-glucose-induced renal proximal tubule injury by targeting GPRC5A
    Shanshan Su, Bao-Peng Li, Chunlin Li, Fangrui Xiu, Dongyan Wang, Farong Zhang · 2020 · Bioscience Biotechnology and Biochemistry
83. Subjective global assessment of nutrition, dialysis quality, and the theory of the scientific method in Nephrology practice
    Lajos Zsom, Marianna Zsom, Sohail Abdul Salim, Tibor Fülöp · 2020 · Artificial Organs
84. Association of Kidney Function With NMR-Quantified Lipids, Lipoproteins, and Metabolic Measures in Mexican Adults
    Diego J. Aguilar-Ramirez, Jesús Alegre-Díaz, William Guy Herrington, Natalie Staplin, Raúl Ramírez-Reyes, Louisa Gnatiuc, Michael Hill, Frederik Romer, Jason Torres, Eirini Trichia et al. · 2021 · The Journal of Clinical Endocrinology & Metabolism
85. Predictors of a Rapid Decline of Renal Function in Patients with Chronic Kidney Disease Referred to a Nephrology Outpatient Clinic: A Longitudinal Study
    Ana Vigil, Emilia Condés, Rosa Camacho, Gabriela Cobo, Paloma Gallar, Aniana Oliet, Isabel Rodríguez, Olimpia Ortega, Carmen Mon, Milagros Ortiz et al. · 2015 · Advances in Nephrology
86. Dialysis initiation improves calcification propensity
    Belén Ponte, Menno T Pruijm, Andreas Pasch, Anne Dufey Teso, Pierre‐Yves Martin, Sophie de Seigneux · 2019 · Nephrology Dialysis Transplantation
87. Need for Better Blood Pressure Measurement in Developing Countries to Improve Prevention of Cardiovascular Disease
    Pietro Amedeo Modesti, Eleonora Perruolo, Gianfranco Parati · 2014 · Journal of Epidemiology
88. Role of mTOR signaling in the regulation of high glucose‑induced podocyte injury
    Qiuyue Li, Yan Zeng, Qing Yan Jiang, Cong Wu, Jing Zhou · 2019 · Experimental and Therapeutic Medicine
89. Chronic kidney disease in adults aged 18 years and older in Chile: findings from the cross-sectional Chilean National Health Surveys 2009–2010 and 2016–2017
    Magdalena Walbaum, Shaun Scholes, Elena Pizzo, Mélanie Paccot, Jennifer Susan Mindell · 2020 · BMJ Open
90. Association between Use of Nutrition Labels and Risk of Chronic Kidney Disease: The Korean National Health and Nutrition Examination Survey (KNHANES) 2008–2019
    Jonghee Kim, Joanne F. Dorgan, Hyesook Kim, Oran Kwon, Yangha Kim, Yuri Kim, Kwang Suk Ko, Yoon Jung Park, Hyesook Park, Seungyoun Jung · 2022 · Nutrients
91. A population cohort analysis of English transplant centers indicates major adverse cardiovascular events after kidney transplantation
    Benjamin M. Anderson, Muhammad Qasim, Felicity Evison, Suzy Gallier, John Townend, Charles Joseph Ferro, Adnan Sharif · 2022 · Kidney International
92. Validation of the FINE-CKD model for future health technology assessments for finerenone in patients with chronic kidney disease and type 2 diabetes
    Michał Pochopień · 2022 · The American Journal of Managed Care
93. Non‐steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes
    Carolina Solis‐Herrera, Curtis L. Triplitt · 2023 · Diabetes Obesity and Metabolism
94. Chronic kidney disease of unknown aetiology in Africa: A review of the literature
    Temesgen Fiseha, Ndianabasi Ekong Ekong, Nicholas John Osborne · 2023 · Nephrology
95. Cost‐effectiveness of finerenone added to standard of care for patients with type 2 diabetes‐related chronic kidney disease in the United States
    Cailin Zheng, Jinneng Wu, Na Li, Xiaoxia Wei, Zhixiong Huang, Lingbin Chen, Zhou Chen · 2024 · Diabetes Obesity and Metabolism
96. Baseline, Early Changes, and Residual Albuminuria
    Dominique van Mil, Priya Vart, Glenn Matthew Chertow, Ron T. Gansevoort, Peter R Rossing, Robert D. Toto, R Correa-Rotter, Anna Maria Langkilde, C. David Sjöström, David Collins. Wheeler et al. · 2024 · Clinical Journal of the American Society of Nephrology
97. SGLT2 inhibitors across the spectrum of chronic kidney disease: a narrative review
    Lance Alan Sloan · 2024 · Postgraduate Medicine
98. Estimated glomerular filtration rate and albuminuria
    Paul V. J. Komenda, Claudio Rigatto, Navdeep Tangri · 2014 · Current Opinion in Nephrology & Hypertension
99. Mineralocorticoid receptor activation as an etiological factor in kidney diseases
    Kohei Ueda, Miki Nagase · 2013 · Clinical and Experimental Nephrology
100. Blood pressure and proteinuria control remains a challenge in patients with type 2 diabetes mellitus and chronic kidney disease: experience from the prospective observational ALICE-PROTECT study
     Jean‐Michel Halimi, Dominique Joly, Christian Combe, Gabriel J. Choukroun, Bertrand Dussol, Jean‐Pierre Fauvel, Stéphane Quéré, B. Fiquet · 2016 · BMC Nephrology